Picture of Thor Medical ASA logo

TRMED Thor Medical ASA News Story

0.000.00%
no flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Nordic Nanovector Publishes Data From Phase 2 Clinical Trials With Betalutin

April 18 (Reuters) - Nordic Nanovector ASA  NANOVN.OL :
    * NORDIC NANOVECTOR PUBLISHES DATA FROM THE PARADIGME PHASE
2
CLINICAL TRIALS WITH BETALUTIN® ON EUROPEAN CLINICAL TRIALS
DATABASE

Source text for Eikon:  ID:nPn2SkjPda 
Further company coverage:  NANOVN.OL 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Thor Medical ASA

See all news